Edition:
United Kingdom

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

2.86USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$2.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,810
52-wk High
$3.30
52-wk Low
$1.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform December 21 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 -0.14 0.07 0.21 -150.00
Quarter Ending Sep-17 -0.22 -0.22 0.00 -0.00
Quarter Ending Mar-17 -0.25 -0.15 0.10 -40.00
Quarter Ending Dec-16 -0.21 -0.36 0.15 -71.43
Quarter Ending Sep-16 -0.42 -0.30 0.12 -28.01

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 --
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-19 0.00 0.00 0.00 0.00 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings